FGFR2 and infantile convulsions and choreoathetosis: The updated analysis of the single-arm FOENIX-CCA2 phase 2 trial included 103 patients with previously-treated advanced or metastatic iCCA with FGFR2 fusions or FGFR2 rearrangements (NCT02052778) [54].